These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 18613437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Jang JY, Kim SW, Kang GH, Yoon YB.
    Ann Surg Oncol; 2007 Nov; 14(11):3195-201. PubMed ID: 17710498
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.
    Hepatogastroenterology; 2002 Nov; 49(44):311-6. PubMed ID: 11995440
    [Abstract] [Full Text] [Related]

  • 5. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB.
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [Abstract] [Full Text] [Related]

  • 8. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Kubo S.
    J Hepatobiliary Pancreat Surg; 2005 Mar; 12(6):479-83. PubMed ID: 16365823
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F.
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [Abstract] [Full Text] [Related]

  • 11. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
    Tajima Y, Kuroki T, Fukuda K, Tsuneoka N, Furui J, Kanematsu T.
    Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
    [Abstract] [Full Text] [Related]

  • 12. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG, Sun LL, Yu WL, Tang ZH, Zong M, Zhang YJ.
    Cancer J; 2009 Jan; 15(3):257-61. PubMed ID: 19556914
    [Abstract] [Full Text] [Related]

  • 13. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL, Zhang YJ, Dong H, Yu H, Xian ZH, Wu MC, Cong WM.
    Zhonghua Wai Ke Za Zhi; 2009 Aug 01; 47(15):1162-6. PubMed ID: 20021908
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y.
    Ann Surg Oncol; 2010 Jul 01; 17(7):1816-22. PubMed ID: 20135355
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.
    Shirabe K, Shimada M, Tsujita E, Aishima S, Maehara S, Tanaka S, Takenaka K, Maehara Y.
    Am J Surg; 2004 Apr 01; 187(4):538-42. PubMed ID: 15041507
    [Abstract] [Full Text] [Related]

  • 16. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M.
    Br J Surg; 2002 Dec 01; 89(12):1525-31. PubMed ID: 12445060
    [Abstract] [Full Text] [Related]

  • 17. [Lymph node metastasis of patients with intrahepatic cholangiocarcinoma].
    Chen Z, Yan JJ, Huang L, Wu MC, Yan YQ.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):454-7. PubMed ID: 16772078
    [Abstract] [Full Text] [Related]

  • 18. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
    Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI.
    J Gastroenterol Hepatol; 2008 May 01; 23(5):766-70. PubMed ID: 17868336
    [Abstract] [Full Text] [Related]

  • 19. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.
    Havlik R, Sbisà E, Tullo A, Kelly MD, Mitry RR, Jiao LR, Mansour MR, Honda K, Habib NA.
    Hepatogastroenterology; 2000 May 01; 47(34):927-31. PubMed ID: 11020850
    [Abstract] [Full Text] [Related]

  • 20. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW, Zhao P, Zhou ZX, Tian YT, Zhao DB, Wang CF.
    Zhonghua Wai Ke Za Zhi; 2009 May 01; 47(9):677-80. PubMed ID: 19615237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.